Catalent Pharma Solutions, Inc. (CTLT)
Dec 18, 2024 - CTLT was delisted (reason: acquired by Novo Holdings)
63.48
0.00 (0.00%)
Inactive · Last trade price on Dec 17, 2024
Catalent Analyst Ratings
Total Analysts
6
Consensus Rating
Hold
Price Target
$63.40
Upside
-0.13%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy → Hold Downgrades $64 | Buy → Hold | Downgrades | $64 | +0.03% | Sep 24, 2024 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 3, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $64 | Hold | Reiterates | $64 | +0.03% | Jul 11, 2024 |
| Barclays | Barclays | Hold Maintains $47 → $63 | Hold | Maintains | $47 → $63 | -0.76% | Jun 28, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $64 | Hold | Reiterates | $64 | +0.03% | Apr 4, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $64 | Hold | Reiterates | $64 | +0.03% | Feb 20, 2024 |
| Stephens & Co. | Stephens & Co. | Buy → Hold Downgrades $64 | Buy → Hold | Downgrades | $64 | +0.03% | Feb 6, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $58 → $64 | Buy → Hold | Downgrades | $58 → $64 | +0.03% | Feb 6, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $58 → $64 | Strong Buy → Hold | Downgrades | $58 → $64 | +0.03% | Feb 6, 2024 |
| Barclays | Barclays | Hold Maintains $45 → $47 | Hold | Maintains | $45 → $47 | -25.96% | Jan 25, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $58 → $55 | Buy | Maintains | $58 → $55 | -13.36% | Nov 16, 2023 |
| Wells Fargo | Wells Fargo | Hold Maintains $50 → $42 | Hold | Maintains | $50 → $42 | -33.84% | Nov 16, 2023 |
| Baird | Baird | Hold → Buy Upgrades $45 → $53 | Hold → Buy | Upgrades | $45 → $53 | -16.51% | Nov 16, 2023 |
| Barclays | Barclays | Hold Maintains $55 → $50 | Hold | Maintains | $55 → $50 | -21.24% | Sep 29, 2023 |
| Argus Research | Argus Research | Hold → Strong Buy Upgrades $62 | Hold → Strong Buy | Upgrades | $62 | -2.33% | Sep 5, 2023 |
| Barclays | Barclays | Hold Maintains $42 → $55 | Hold | Maintains | $42 → $55 | -13.36% | Sep 1, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.